UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1051P Radiotherapy (RT) and efficacy of immune checkpoint inhibitors (ICI), chemotherapy (CTx) and chemoimmunotherapy (CIT) in patients with non-small cell lung cancer (NSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1035-S1036

2022

Volltextzugriff (PDF)

1279P The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)

Annals of oncology, 2021-09, Vol.32, p.S996-S996

2021

Volltextzugriff (PDF)

1359P Lack of Abscopal effect and radiotherapy-induced lymphocyte depletion in advanced non-small cell lung cancer (NSCLC) patients treated with atezolizumab and radiotherapy

Annals of oncology, 2024-09, Vol.35, p.S857-S857

2024

Volltextzugriff (PDF)

1454P Optimizing ipilimumab in RCC: Results from SAKK 07/17 (CM-980) nivolumab (N) + ipilimumab (Ipi) in mRCC

Annals of oncology, 2022-09, Vol.33, p.S1209

2022

Volltextzugriff (PDF)

1623P Prognostic value of circulating tumour DNA fraction in metastatic castration-resistant prostate cancer: Insights from the ProBio trial

Annals of oncology, 2024-09, Vol.35, p.S980-S980

2024

Volltextzugriff (PDF)

1737MO Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial

Annals of oncology, 2022-09, Vol.33, p.S1331

2022

Volltextzugriff (PDF)

2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)

European journal of cancer (1990), 2015-09, Vol.51, p.S473-S473

2015

Volltextzugriff (PDF)

2571 A high baseline neutrophil count may predict poor prognostic outcome in mCRPC: A post-hoc analysis of the TROPIC phase III trial

European journal of cancer (1990), 2015-09, Vol.51, p.S501-S501

2015

Volltextzugriff (PDF)

28P 3-year follow-up analysis of disease-free survival in CheckMate 274 by PD-L1 expression using tumor cell and combined positive scoring algorithms

Immuno-oncology technology, 2023-12, Vol.20, p.100497, Article 100497

2023

Volltextzugriff (PDF)

637P The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial

Annals of oncology, 2020-09, Vol.31, p.S524-S525

2020

Volltextzugriff (PDF)

6655 The emerging role of the novel serum marker GOLPH2 in detecting and monitoring of hepatocellular carcinoma

European journal of cancer supplements, 2009, Vol.7 (2), p.404-405

2009

Volltextzugriff (PDF)

716P Optimizing ipilimumab in metastatic renal cell carcinoma: SAKK 07/17 study

Annals of oncology, 2020-09, Vol.31, p.S563-S563

2020

Volltextzugriff (PDF)

785PEARLY NEUTROPENIA IS ASSOCIATED WITH SURVIVAL IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) WHEN TREATED WITH CABAZITAXEL: AN ANALYSIS OF TROPIC PHASE III TRIAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv271-iv271

2014

Volltextzugriff (PDF)

811PAssociation of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

A0529 - Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1418-S1418

2024

Volltextzugriff (PDF)

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1424-S1424

2024

Volltextzugriff (PDF)

Accessory parotid gland lesions: case report and review of literature

European archives of oto-rhino-laryngology, 2008-09, Vol.265 (9), p.1135-1138

2008

Volltextzugriff (PDF)

Acting without being in control: Exploring volition in Parkinson's disease with impulsive compulsive behaviours

Parkinsonism & related disorders, 2017-07, Vol.40, p.51-57

2017

Volltextzugriff (PDF)

Adenocarcinoma of the ampulla of Vater and head of the pancreas metastatic to the ureter: report of 2 cases

The Journal of urology, 1996-11, Vol.156 (5), p.1765-1765

1996

Volltextzugriff (PDF)

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma

Immuno-oncology technology, 2024-08, p.100728, Article 100728

2024

Volltextzugriff (PDF)

AF super( beta ) sub(1-28) Fragment of the Amyloid Peptide Predominantly Adopts a Polyproline II Conformation in an Acidic Solution

Biochemistry (Easton), 2004-06, Vol.43 (22), p.6893-6898

2004

Volltextzugriff (PDF)

After care in Hodgkin lymphoma

Praxis (Bern. 1994), 2011-12, Vol.100 (25), p.1515

2011

Volltextzugriff (PDF)

Analysis of disease-free survival in CheckMate 274 by PD-L1 combined positive score and tumor proportion score

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.491-491

2022

Volltextzugriff (PDF)

Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system

Anticancer research, 2013-10, Vol.33 (10), p.4189-4201

2013

Volltextzugriff (PDF)

Association of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel

Annals of oncology, 2018-10, Vol.29, p.viii280-viii281

2018

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(118)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

1051P Radiotherapy (RT) and efficacy of immune checkpoint inhibitors (ICI), chemotherapy (CTx) and chemoimmunotherapy (CIT) in patients with non-small cell lung cancer (NSCLC)

1279P The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)

1359P Lack of Abscopal effect and radiotherapy-induced lymphocyte depletion in advanced non-small cell lung cancer (NSCLC) patients treated with atezolizumab and radiotherapy

1454P Optimizing ipilimumab in RCC: Results from SAKK 07/17 (CM-980) nivolumab (N) + ipilimumab (Ipi) in mRCC

1623P Prognostic value of circulating tumour DNA fraction in metastatic castration-resistant prostate cancer: Insights from the ProBio trial

1737MO Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial

2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)

2571 A high baseline neutrophil count may predict poor prognostic outcome in mCRPC: A post-hoc analysis of the TROPIC phase III trial

28P 3-year follow-up analysis of disease-free survival in CheckMate 274 by PD-L1 expression using tumor cell and combined positive scoring algorithms

637P The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial

6655 The emerging role of the novel serum marker GOLPH2 in detecting and monitoring of hepatocellular carcinoma

716P Optimizing ipilimumab in metastatic renal cell carcinoma: SAKK 07/17 study

785PEARLY NEUTROPENIA IS ASSOCIATED WITH SURVIVAL IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) WHEN TREATED WITH CABAZITAXEL: AN ANALYSIS OF TROPIC PHASE III TRIAL

811PAssociation of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel

A0529 - Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

Accessory parotid gland lesions: case report and review of literature

Acting without being in control: Exploring volition in Parkinson's disease with impulsive compulsive behaviours

Adenocarcinoma of the ampulla of Vater and head of the pancreas metastatic to the ureter: report of 2 cases

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma

AF super( beta ) sub(1-28) Fragment of the Amyloid Peptide Predominantly Adopts a Polyproline II Conformation in an Acidic Solution

After care in Hodgkin lymphoma

Analysis of disease-free survival in CheckMate 274 by PD-L1 combined positive score and tumor proportion score

Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system

Association of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel

Suchergebnisse filtern